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Blood-borne phagocytes internalize 
urate microaggregates and prevent 
intravascular NETosis by urate 
crystals
Elmar Pieterse1,2, Ivica Jeremic2,3, Christine Czegley2, Daniela Weidner2, 
Mona H.C. Biermann2, Susan Veissi2, Christian Maueröder2, Christine Schauer2, 
Rostyslav Bilyy2,4, Tetiana Dumych4, Markus Hoffmann2, Luis E. Munoz2, 
Anders A. Bengtsson5, Georg Schett2, Johan van der Vlag1,* & Martin Herrmann2,*
Hyperuricemia is strongly linked to cardiovascular complications including atherosclerosis and 
thrombosis. In individuals with hyperuricemia, needle-shaped monosodium urate crystals (nsMSU) 
frequently form within joints or urine, giving rise to gouty arthritis or renal calculi, respectively. These 
nsMSU are potent instigators of neutrophil extracellular trap (NET) formation. Little is known on the 
mechanism(s) that prevent nsMSU formation within hyperuricemic blood, which would potentially 
cause detrimental consequences for the host. Here, we report that complement proteins and fetuins 
facilitate the continuous clearance by blood-borne phagocytes and resident macrophages of small 
urate microaggregates (UMA; <1 μm in size) that initially form in hyperuricemic blood. If this 
clearance fails, UMA exhibit bipolar growth to form typical full-sized nsMSU with a size up to 100 μm. 
In contrast to UMA, nsMSU stimulated neutrophils to release NETs. Under conditions of flow, nsMSU 
and NETs formed densely packed DNase I-resistant tophus-like structures with a high obstructive 
potential, highlighting the importance of an adequate and rapid removal of UMA from the circulation. 
Under pathological conditions, intravascularly formed nsMSU may hold the key to the incompletely 
understood association between NET-driven cardiovascular disease and hyperuricemia.
Hyperuricemia (uric acid blood levels ≥ 6 (women) or 6.8 (men) mg/dL) is the major risk factor for the devel-
opment of gout1,2. When the concentration of uric acid exceeds its solubility limit, monosodium urate crystals 
(cMSU) may form. Such cMSU initially appear as round-shaped bifringent urate microaggregates (UMA; ≤ 1 μ m 
in size), which can subsequently grow in a bipolar manner to form needle-shaped monosodium urate crystals 
(nsMSU; up to 100 μ m in size)3. In gout, arthritis occurs due to the deposition of nsMSU in the peripheral joints. 
These nsMSU may also develop within the urine, giving rise to renal calculi. The inflammatory response towards 
nsMSU is in part characterized by neutrophils that undergo oxidative burst and release their chromatin as neutro-
phil extracellular traps (NETs) during a process known as NETosis4–7. NETs are found in the synovial fluids and 
tissue of patients with gout, especially in those with gouty flares or granuloma formation4,8. At high neutrophil 
densities, NETs and nsMSU can form densely packed aggregates, that appear as tophus-like structures9,10.
In contrast to the synovial fluids or urine of hyperuricemic patients, the presence of nsMSU has never been 
described in blood. The presence of nsMSU in blood could have detrimental consequences for the host, since 
the intravascular formation of nsMSU and the consecutive induction of NETosis bear the risk of life-threatening 
atherosclerosis, increased vascular permeability, and thrombosis11–13.
1Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands. 2Department 
of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. 3Institute of 
Rheumatology, Resavska 69, Belgrade, Serbia. 4Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. 
5Department of Rheumatology, University Hospital of Lund, Lund, Sweden. *These authors jointly supervised this work. 
Correspondence and requests for materials should be addressed to L.E.M. (email: Luis.Munoz@uk-erlangen.de) or 
J.v.d.V. (email: Johan.vandervlag@radboudumc.nl)
Received: 24 May 2016
Accepted: 07 November 2016
Published: 05 December 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:38229 | DOI: 10.1038/srep38229
In the present study, we investigated the crystallization of uric acid in hyperuricemic blood. We elucidated a 
novel mechanism by which blood-borne phagocytes remove small UMA initially formed in hyperuricemic blood 
before these can actually develop into NET-inducing nsMSU. If this mechanism fails, nsMSU and NETs form 
DNase I-resistant tophus-like aggregates with a high obstructive potential.
Results
Uric acid crystallizes in hyperuricemic serum and whole blood ex vivo. To assess whether high 
uric acid levels can promote crystal formation in serum or whole blood, we analyzed samples from eight hyper-
uricemic patients and normouricemic normal healthy donors ex vivo. Uric acid levels in hyperuricemic patients 
were above 12 mg/dL, thereby exceeding the theoretical threshold of solubility for uric acid. Serum and whole 
blood was incubated at 4 °C or 37 °C and analyzed for crystalline structures at set time points using polarized light 
microscopy. After 6 hours of incubation, round-shaped UMA were observed in the sera of hyperuricemic patients 
(Fig. 1a) but not in those from healthy donors (not shown). Prolonged incubation (up to 24 hours) did not further 
increase UMA formation in hyperuricemic serum (Fig. 1b). Furthermore, healthy donor sera remained negative 
for UMA after ex vivo incubation up to 72 hours (not shown). In whole blood smears, we also detected UMA after 
6 hours of incubation ex vivo. However, UMA were exclusively present within blood-borne phagocytes (Fig. 1c). 
Based on these observations, we hypothesized that blood-borne phagocytes clear UMA from hyperuricemic 
blood, thereby preventing intravascular formation of nsMSU and the consecutive induction of NETosis.
Blood-borne phagocytes rapidly internalize UMA. To determine whether blood-borne phagocytes 
internalize UMA, we incubated healthy donor whole blood with in vitro generated UMA and evaluated their 
uptake by blood-borne phagocytes by flow cytometry and polarized light microscopy. In response to UMA, 
CD14+ monocytes dose-dependently displayed an increased side scatter when compared to untreated cells 
(Fig. 2a). A similar result was observed for CD16+ neutrophils. To confirm that the increased side scatter rep-
resented UMA internalization, we exposed neutrophils to UMA in the presence of pHrodo, which is a dye that 
becomes co-ingested during phagocytosis and which becomes fluorescent in the acidic milieu of the phago-
some. Indeed, neutrophils with an increased side scatter were positive for pHrodo, in contrast to neutrophils 
with a normal side scatter, thereby confirming uptake of UMA (Supplementary Figure 1a,b and c). Importantly, 
the phagocytic index (PhIx) of cells exposed to UMA, as calculated by multiplying the percentage of cells with 
increased side scatter with the mean side scatter value, directly correlated to the mean fluorescence intensity of 
Figure 1. Uric acid crystallizes in hyperuricemic serum and whole blood ex vivo. (a) Small, round-shaped 
urate microaggregates (UMA) developed after in vitro incubation of hyperuricemic serum. Representative 
images are shown. (b) Crystallization of uric acid preferentially occurred at colder temperatures and was 
saturated after 6 hours of incubation of hyperuricemic serum. The amount of UMA was scored by polarized 
light microscopy whereby the number of UMA per field of view (FOV; 200x magnification) was scored.  
(c) Incubation of hyperuricemic whole blood for 6 hours ex vivo showed intracellular presence of UMA within 
blood-borne phagocytes (white arrows) in blood smears. Red arrows represent erythrocytes. Representative 
images are shown from two hyperuricemic gout patients. Scale bars: 20 μ m (inserts: 5 μ m).
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pHrodo (Supplementary Figure 1d). Finally, the uptake of UMA by neutrophils was recorded using polarized 
light microscopy (Fig. 2b; Movie S1).
Complement proteins and fetuins facilitate phagocytosis of UMA. It has been previously reported 
that complement can be activated by nsMSU resulting in opsonization14–17. To assess a possible role for comple-
ment proteins in the phagocytosis of UMA, we stimulated purified neutrophils with UMA in the presence of (I) 
10% active autologous serum, (II) 10% heat-inactivated serum, (III) 10% autologous Ca2+-depleted serum by 
EDTA (500 μ M) or 10% autologous serum supplemented with either (IV) heat-aggregated IgG (1 mg/mL) or (V) 
cobra venom factor (20 U/ml). The two latter treatments (IV, V) cause complement consumption and depletion. 
Thus, only the fresh autologous serum (I) contained active complement and supported the uptake of UMA into 
purified neutrophils (Fig. 2c, Supplementary Figure 1e). Heat-aggregated IgG and EDTA are broad-spectrum 
inhibitors of the complement system, whereas cobra venom factor specifically inhibits the alternative pathway 
due to C3 consumption. To more specifically investigate the role of the classical complement pathway in UMA 
phagocytosis, we performed these assays in 10% serum derived from patients deficient in complement factors 
C4A, C4B, C4, C2 and C1q. All complement-deficient patients showed an impaired/abrogated uptake of UMA 
(Fig. 2d).
Fetuins are carrier proteins that bind and solubilize crystal germs from calcium phosphate18. Therefore, we 
tested whether fetuins also facilitated the phagocytosis of UMA. We observed an increase of 40% in the phago-
cytosis of UMA by neutrophils when 10% active autologous serum was supplemented with 1 mg/mL fetuin or its 
desialyated form asialofetuin (Fig. 2e). Interestingly, employing 10% heat-inactivated autologous serum, neither 
asialofetuin nor fetuin facilitated the phagocytosis of UMA by neutrophils. Taken together, our data reveal a 
cooperative mechanism between fetuins and complement proteins in facilitating the phagocytosis of UMA by 
neutrophils.
Figure 2. Blood-borne phagocytes rapidly internalize UMA. (a) Whole blood was incubated with 100 
or 200 μ g/ml UMA. Then their uptake by CD14+ monocytes (‘mono’) or CD16+ neutrophils (‘PMN’) was 
assessed by flow cytometry. (b) Purified neutrophils contained UMA as soon as 15 min after incubation. 
(c) Purified neutrophils ingested significantly more UMA in the presence of fresh serum containing active 
complement (left bar), whereas heat inactivation (H.I; 30 min, 56 °C) of serum or treatment of active serum 
with cobra venom factor (CVF; 20U/ml), EDTA (500 μ M) and heat-aggregated IgG (1 mg/ml) prevents UMA 
ingestion. (d) Uptake of UMA by purified neutrophils was impaired in the presence of complement deficient 
sera (C4A, n = 3; C4B, n = 2; C4, n = 1; C2, n = 3; C1q, n = 1), when compared to sera from normal healthy 
donors (NHD, n = 10). (e) Spiking active serum with fetuin (1 mg/ml) or its enzymatically desialyated form 
asialofetuin (1 mg/ml) boosts the phagocytosis of UMA by neutrophils. Scale bars: 20 μ m (inserts: 10 μ m). 
***p < 0.001, **p < 0.01, *p < 0.05, when compared to control situation where not indicated. The phagocytic 
indices (PhIx) were calculated by multiplying the percentage of cells with increased side scatter by the mean side 
scatter value.
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Macrophages recognize and clear UMA-loaded phagocytes. Macrophages and neutrophils share 
cooperative effector activities, of which one modality comprises the ability of macrophages to internalize neu-
trophils that express “eat-me” signals19. We hypothesized that the ingestion of UMA by blood-borne phagocytes 
results in the clearance of these cells by splenic and/or hepatic macrophages. To test this, we incubated puri-
fied neutrophils with UMA and performed co-culture experiments with monocyte-derived macrophages. After 
4 hours of co-culture with macrophages, the amount of UMA-loaded neutrophils was significantly reduced, 
whereas naive neutrophil counts remained stable (Fig. 3a, left panel). Notably, in particular the percentage of 
neutrophils with an increased side scatter decreased in these co-cultures (Fig. 3a, right panel; Fig. 3b). In line with 
this, we confirmed by immunofluorescence microscopy that neutrophils were observed within or attached to 
macrophages when these neutrophils had been loaded with UMA (Fig. 3c). The uptake of UMA-loaded neutro-
phils by macrophages was further confirmed by using neutrophils pre-labeled with pHrodo. A pHrodo-derived 
fluorescent signal was obtained after co-culturing macrophages with neutrophils pre-loaded with UMA, in 
Figure 3. Monocyte-derived macrophages recognize and engulf UMA-containing neutrophils. (a) After co-
incubation with macrophages for 4 hours, the amount of UMA-stimulated neutrophils, normalized to neutrophils 
before co-culture, significantly declined in culture supernatants (left panel). Particularly the percentage of 
neutrophils with an increased side scatter decreased in these co-cultures (right panel). (b) Representative flow 
cytometry charts showing that macrophages selectively recognize neutrophils with an increased side scatter 
(gate A). (c) PKH26-labeled neutrophils (red; PMN) are either attached to or taken up by monocyte-derived 
macrophages (green), where unstimulated neutrophils (control) are not. (d) pHrodo-labeled neutrophils pre-
loaded with UMA are engulfed by macrophages, whereas neutrophils not exposed to UMA are not. Scale bars: 
20 μ m. ***p < 0.001, *p < 0.05, when compared to control situation where not indicated.
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contrast to neutrophils that were not exposed to UMA (Fig. 3d). Finally, to assess how macrophages may recog-
nize UMA-loaded neutrophils, we analyzed the expression of phosphatidyl serine (PS; expressed on apoptotic 
cells), CD11a/CD18 (LFA-1) and CD31 on neutrophils before and after exposure to UMA. Notably, it has previ-
ously been shown that these cell surface markers facilitate interactions between neutrophils and macrophages20–22. 
We observed that UMA-loaded neutrophils remained viable, i.e. did not expose PS, and did not alter LFA-1 
expression, whereas CD31 expression was diminished (Supplementary Figure 2). In conclusion, macrophages 
recognize and engulf neutrophils loaded with UMA, which is possibly facilitated by the loss of CD31 expression.
Impaired UMA clearance promotes nsMSU-induced NET release. We observed that UMA ulti-
mately grow at their longitudinal ends into nsMSU (15–20 μ m in size) in the absence of phagocytes (Fig. 4a; 
Movie S2). The growth of UMA into nsMSU also occurred in the presence of phagocytes and heat-inactivated 
hyperuricemic serum, thus in a condition in which the clearance of UMA by phagocytes is impaired due to the 
lack of complement proteins (Supplementary Figure 3). In contrast, nsMSU were not observed in the presence 
of phagocytes and hyperuricemic serum that was not heat-inactivated. Collectively, these data indicate that the 
impaired clearance of UMA by blood-borne phagocytes can promote the development of nsMSU in hyperu-
ricemic serum. Since neutrophils can sense microbe sizes and selectively release NETs toward large pathogens23, 
we assessed whether the size of crystals (UMA versus nsMSU) influences NET release. For this purpose, we 
incubated purified neutrophils for 4 hours separately with UMA (≤ 1 μ m) or nsMSU (15–20 μ m) and analyzed 
ROS production, extracellular DNA release and the presence of citrullinated histone H3 as markers of NETosis. 
Neutrophils stimulated with UMA had a highly granular phenotype, indicative for the uptake of these crystals, 
but barely stained positive for citrullinated histone H3 (Fig. 4b,c, left panel). In line with this, no extracellular 
Figure 4. Impaired phagocytosis of UMA leads to the formation of nsMSU with NET-inducing potential. 
(a) In the absence of phagocytes, nsMSU developed in hyperuricemic serum. (b) Ingestion by neutrophils 
of huge amounts of UMA and nsMSU (left panels) caused moderate and substantial hypercitrullination of 
histone H3 in cultured granulocytes (right panels, white arrows), respectively. (c) Citrullination of histone H3 
(left panel) and release of DNA (middle panel) preferentially occurred in response to nsMSU, whereas ROS 
production was significantly higher in response to both UMA as well as nsMSU (right panel). Scale bars: 30 μ m 
(inserts: 10 μ m). ***p < 0.001, *p < 0.05.
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DNA was detected when neutrophils were incubated with UMA (Fig. 4c, middle panel). In contrast, nsMSU pro-
moted substantial citrullination of histone H3 and induced robust DNA release by neutrophils. Intriguingly, ROS 
production was increased in response to both UMA and nsMSU with a reciprocal difference in favor of UMA 
(Fig. 4c, right panel). Taken together, these data indicate that neutrophils can distinguish small from big crystals 
and selectively release NETs in response to the longer nsMSU, which can occur when UMA are insufficiently 
cleared.
Intravenously injected UMA end up in the spleen and liver. When we injected 1 mg UMA intrave-
nously in the tail vein of Balb/c mice, we observed the crystals ended up within the sinusoids of the liver and in 
the marginal zones of the spleen, whereas the heart and kidneys contained no UMA (Fig. 5a). Blood smears from 
these mice did not contain UMA either (not shown). Only a few UMA were observed within the lungs (Fig. 5b), 
which appeared a bit larger in size than regular UMA. The observation that the lungs, which are the first organs 
to pass after injecting UMA in the tail vein, contained very little UMA implies that UMA are cleared from the 
circulation by specific organs, i.e. the spleen and the liver. Experiments with nsMSU could not be performed 
in vivo since these crystals caused sudden death in pilot experiments. Therefore, we studied nsMSU under con-
dition of flow in vitro.
Under venous flow, UMA and nsMSU both induce NETosis.  Next, we repeated our assays under 
conditions simulating a venous flow rate. At high crystal concentrations used in earlier experiments, we observed 
that UMA and nsMSU formed tiny and massive crystal aggregates, respectively (Fig. 6a). This appeared to be 
a physical flow-dependent process occurring in the absence of leukocytes. However, the high concentration 
of UMA is a non-physiological condition, since our data suggest that UMA are unable to reach these con-
centrations under physiological conditions due to their rapid clearance by blood-borne phagocytes. The size 
of these aggregates drastically increased in the presence of leukocytes (Fig. 6b, left panels ‘Brightfield’) form-
ing macroscopic tophus-like structures with a diameter of up to 3 mm (Fig. 6b, right panels ‘Macroscopic’). 
Further analyses revealed that these aggregates contained high amounts of extracellular DNA (Fig. 6b, mid-
dle panels ‘Immunofluorescence’) with nsMSU and UMA at high doses. In contrast to static culture conditions, 
high amounts of UMA aggregates appear capable of inducing NETosis under flow. This is presumably caused 
by physical aggregation of these crystals forming structures too large for immediate phagocytic clearance. The 
extracellular DNA appeared particularly densely packed in nsMSU aggregates. Importantly, DNA aggregates 
containing nsMSU resisted digestion by DNase I, most likely by stabilization of the aggregate by the large sized 
crystal framework, whereas UMA-containing DNA aggregates were sensitive to DNase I and got fully dissolved 
(Fig. 6b, middle panels ‘Immunofluorescence’). Notably, nsMSU-containing DNA aggregates contained much 
Figure 5. Circulating UMA undergo splenic and hepatic clearance in vivo. (a) Intravenously injected UMA 
(1 mg) are cleared in mice in the sinusoids of the liver or in the marginal zone of the spleen (yellow arrows 
indicate UMA), whereas other organs contained no (heart, kidneys) to very little (lungs) UMA. (b) The amount 
of UMA per organ were quantified by analyzing at least four different fields of view (FOV) at 200x magnification 
for the presence of UMA. Scale bar: 100 μ m. **p < 0.01, #p < 0.001 compared to lung, heart and kidney, 
^p < 0.001 compared to heart and kidney.
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more myeloperoxidase activity, neutrophil elastase activity, and extracellular DNA than UMA-containing DNA 
aggregates (Fig. 6c). In sum, UMA and nsMSU induce NETosis under flow, by which large macroscopic aggre-
gates of NETs and crystals are formed. However, the UMA-based aggregates are readily dismantled by DNase I.
Figure 6. cMSU-induced NETosis promotes tophus formation. (a) Under conditions of flow, high 
concentrations of UMA and nsMSU formed large aggregates of crystals. (b) Leukocytes were attracted to UMA 
and nsMSU aggregates (left panels) and released NETs (DNase-INEG; middle panels), thereby forming macroscopic 
tophus-like structures (right panels). Aggregates of NETs and nsMSU resisted DNase I-mediated degradation 
(DNase-IPOS; middle panels), whereas UMA-induced NETs were completely dissolved. (c) nsMSU-containing 
tophi were highly positive for active myeloperoxidase (MPO), neutrophil elastase (NE) and extracellular DNA. 
Scale bars: (a) 30 μ m (inserts: 10 μ m); (b) ‘brightfield’ 30 μ m, ‘immunofluorescence’ 100 μ m, ‘macroscopic’ 3 mm. 
^p < 0.001 compared to control situation, $p < 0.05 compared to control situation, ***p < 0.001 between indicated 
conditions.
www.nature.com/scientificreports/
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NETosis shields endothelial cells from pro-inflammatory UMA and nsMSU. Intravascular 
NETosis was previously linked to an altered vascular integrity during acute lung injury13. We therefore assessed 
the consequences of UMA- and nsMSU-induced NET formation on endothelial cells. For this purpose, we stim-
ulated confluent HUVEC monolayers under flow for 6 hours with UMA or nsMSU. In the absence of leuko-
cytes, both UMA and nsMSU induced an upregulation of TNF-α and IL-6 mRNA in HUVEC, whereas TGF-β 
mRNA levels remained constant (Fig. 7a). However, in the presence of leukocytes (i.e. erythrocyte-depleted whole 
blood), TNF-α and IL-6 mRNA levels in HUVEC were not upregulated compared to unstimulated HUVEC, 
indicating that leukocytes shield endothelial cells from the pro-inflammatory effects of cMSU. Notably, we did not 
observe cytotoxicity of these structures to endothelial cells despite the formation of large macroscopic aggregates 
Figure 7. NETosis protects endothelial cells from the pro-inflammatory effects of cMSU. (a) UMA and 
nsMSU induce mRNA upregulation in HUVEC of tumor necrosis factor α (TNF-α ) and interleukin 6 (IL-6), 
whereas mRNA expression of transforming growth factor β (TGF-β ) remained constant. The upregulation of 
TNF-α and IL-6 mRNA in HUVEC was prevented by the presence of leukocytes (i.e. erythrocyte-depleted 
whole blood). (b) Immunofluorescence imaging of HUVEC shows that tophus-like structures of UMA or 
nsMSU and extracellular DNA does not promote release of von Willebrand factor (vWF; upper panels), nuclear 
translocation of NFKB p65 (middle panels) or loss of VE-cadherin (CD144)-mediated junctions (lower panels). 
Scale bar: 20 μ m. ^p < 0.001 compared to control, ***p < 0.001 between indicated conditions, **p < 0.05 
between indicated conditions.
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in culture supernatants, which contained cytotoxic histones and active proteases. The endothelial cells and the 
integrity of the endothelial monolayer remained intact, as determined by immunofluorescence imaging of the 
adherens junction protein VE-cadherin (CD144) (Fig. 7b). In addition, we found no release of von Willebrand 
factor (vWF) or nuclear translocation of NFKB (Fig. 7b), indicating that endothelial cells are also not activated by 
these cMSU-containing aggregates. Interestingly, immunofluorescence imaging revealed that UMA-stimulated 
leukocytes adhered significantly more to endothelial cells than unstimulated or nsMSU-stimulated leukocytes 
(not shown). In summary, leukocytes protect endothelial cells from cMSU-induced damage.
Discussion
The formation and growth of cMSU is a complex process that is influenced by multiple factors, including tem-
perature, calcium levels, pH and/or mechanical shock24. Preferentially, nsMSU develop within the relatively cold 
synovial fluids or within the acidic urine, giving rise to gouty arthritis and renal calculi, respectively. Whether 
uric acid also crystallizes within hyperuricemic blood has long been a subject of debate. The observation that the 
solubility of uric acid increases in the presence of albumin has supported the notion that uric acid does not form 
crystals in blood25. However, the role of albumin in uric acid crystallization is controversial. Some investigators 
suggested that albumin strongly inhibits nsMSU formation, some claimed that albumin has absolutely no effect, 
while others reported that albumin accelerates the crystallization process3. Our data refute the notion that albu-
min inhibits uric acid crystallization. We found that small, round-shaped UMA developed within hyperuricemic 
serum as well as whole blood ex vivo. These UMA were taken up by blood-borne phagocytes and cleared from the 
circulation. They finally ended up in the sinusoids of liver and in the spleen.
The abundant plasma proteins fetuin (also known as alpha-2-HS-glycoprotein) and complement promoted 
the clearance of UMA by blood-borne phagocytes. Indeed, complement proteins can bind to and get activated by 
nsMSU14–16. A role for fetuin in the phagocytosis of crystallized uric acid has not been reported yet, although the 
contribution to the clearance of calprotein-like particles26, apoptotic cells27 and polystyrene nanospheres28 is well 
established. Interestingly, fetuin enhanced the phagocytosis of UMA only in the presence of active complement. 
Cooperative effects of fetuin and serum proteins were previously reported in the context of calcium phosphate 
crystal nidi29. UMA intravenously injected into mice were traced back in the sinusoids of the liver and the mar-
ginal zones of the spleen (Fig. 5), which are both areas known to harbor specialized macrophages classified as 
part of the reticuloendothelial system30–33. Resident tissue macrophages in the liver and spleen are discretely 
positioned and transcriptionally programmed for the encounter of pathogens or environmental challenges, thus 
serving as immune sentinels34. Our observations thus suggest that the clearance of UMA by blood-borne phago-
cytes ultimately results in their hepatic or splenic exit from the circulation, where specialized macrophages sense 
UMA-loaded phagocytes35. The phagocytosis by macrophages of UMA-loaded neutrophils may be facilitated 
through the observed loss of CD31 on neutrophils that contain UMA. It has been proposed that CD31 expression 
on neutrophils prevents the ingestion of neutrophils by macrophages through transmitting active ‘detachment’ 
signals, whereby the loss of CD31 thus facilitates the ingestion of neutrophils by macrophages20.
In hyperuricemic serum, in the absence of leukocytes, punctate UMA slowly formed and subsequently grew 
to nsMSU (Movie S2). The whole process is kinetically controlled and takes several hours. In contrast to UMA, 
single nsMSU triggered the release of potentially pro-coagulant NETs by blood-borne neutrophils in static culture 
conditions. Thus, an impaired clearance of UMA may bear the risk for thrombus formation and vascular injury. 
From previous work, we know that the release of NETs in response to nsMSU involves the generation of ROS4. We 
observed that both UMA and nsMSU induced ROS production in neutrophils, whereas citrullination of histone 
H3 and DNA release, two major hallmarks of NETosis, were particularly observed in response to nsMSU. This 
suggests that the inflammatory response of neutrophils towards crystallized uric acid is dependent on the size of 
the crystals. Indeed, neutrophils possess the ability to sense pathogen size23. The observation that high amounts 
of UMA, forming extended aggregates under conditions of flow, induced NETosis supports this line of thought.
In contrast to other work36,37, we did not observe cytotoxic effects of crystal-induced NETs to endothelial cells. 
Instead, the presence of leukocytes prevented the pro-inflammatory effects of UMA and nsMSU to endothelium. 
This process involved the trapping of the crystals by extended aggregated NETs. Thus, although it is generally 
accepted that cMSU act pro-inflammatory through ligation of toll like receptors and subsequent activation of 
NFKB signaling38–40, the pro-inflammatory effects of cMSU are reduced when these are entrapped within NETs. 
Of note, we found that DNase I only dismantled and dissolved UMA-containing aggregated NETs, whereas those 
composed of nsMSU were rather resistant to DNase I activity.
Altogether, we propose a model in which complement proteins and fetuins facilitate the cooperative clearance 
by blood-borne phagocytes and resident macrophages of UMA that spontaneously form in hyperuricemic blood 
(Fig. 8). The relevance of this clearance mechanism is reflected by the capacity of nsMSU to induce NETosis, 
which may have detrimental effects if it occurs in the vasculature. In otherwise healthy individuals with hype-
ruricemia, UMA will be cleared from the circulation in statu nascendi. This prevents a further crystal growth 
and the formation of potentially hazardous nsMSU. Since the clearance of UMA is significantly impaired in the 
absence of complement factors or fetuin, patients with chronic kidney disease and/or low levels of these plasma 
proteins41–45 may potentially be at risk to develop chronic NET-driven vascular inflammation.
Materials and Methods
Patient material. Serum and heparinized whole blood was collected from eight hyperuricemic patients 
and normouricemic controls and uric acid concentrations were determined by routine laboratory methods. All 
patient samples analyzed were anonymously donated to our research faculty and exceeded a uric acid concentra-
tion of 12 mg/dL. Some samples were found to be hypersaturated with uric acid up to 21 mg/dL, fairly above the 
solubility limit of approximately 7 mg/dL. Serum and whole blood was incubated at 4 °C and 37 °C and analyzed 
for the formation of crystalline structures employing polarized light video microscopy. Healthy donors served as 
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controls. For some experiments, serum was collected from complement deficient patients (C4A, C4B, C4, C2 or 
C1q). Informed consent for blood donation was obtained from all subjects for all methods. All experiments with 
human material were performed in accordance with institutional guidelines and were approved by the Ethical 
committee of the University Hospital Erlangen.
Animals. Balb/c mice were bred at the Danylo Halytsky Lviv National Medical University, Lviv, Ukraine, 
during Jan – August 2014 and kept on a standard diet with drinking water available ad libitum. All animal studies 
were performed in accordance with the guidelines determined by Law of Ministry of Healthcare of Ukraine, No. 
281 from 01.11.2011 for the care and use of laboratory animals and approved by Ethics Council of the Danylo 
Halytsky Lviv National Medical University, protocol 1/6, dated June 24, 2013.
Clearance of UMA in vivo. For in vivo experiments, 1 mg UMA or nsMSU were intravenously injected in 
250 μ l PBS into Balb/c mice. Cryosections of heart, kidneys, lungs, spleen and liver were prepared without any 
fixation 24 hours after the injection and analyzed by polarized light microscopy. Since animals immediately died 
after injection of nsMSU, we only used UMA for our final analyses for ethical reasons.
Isolation of neutrophils. Neutrophils were isolated from heparinized (20 U/mL) blood by density gradi-
ent centrifugation using Lymphoprep (Stemcell Technologies). Briefly, whole blood was diluted 1:1 in PBS to a 
volume of 30 mL and slowly layered on top of 15 mL Lymphoprep. The blood was then centrifuged at 800 g for 
20 minutes and neutrophils were collected from the high density fraction. Residual erythrocytes were eliminated 
by repetitive hypotonic lysis. Viable neutrophils were counted in a Neubauer cell counting chamber.
Phagocytosis assays. For ex vivo phagocytosis experiments, anticoagulated fresh whole blood was incu-
bated at 37 °C with UMA. Erythrocytes were subsequently removed by hypotonic lysis. Leukocytes were stained 
with anti-CD16 (cat. no. B-E16-FITC, Abcam) and anti-CD14 (cat. no. 61D3-PE, eBioscience) and analyzed by 
flow cytometry. For in vitro phagocytosis experiments, purified neutrophils (2 × 106 cells/ml) were stimulated 
with 50 pg of UMA per cell in the presence of 10% autologous serum. Serum had been pre-treated as indicated. 
The phagocytic indices (PhIx) for UMA were calculated by multiplying the percentage of cells with increased side 
scatter with the mean side scatter value. Where indicated, phagocytosis was confirmed by exposing neutrophils 
to UMA in the presence of 100 nM pHrodo Red SE (Life Technologies) and subsequently analyzing cell-borne 
fluorescence by flow cytometry. Flow cytometry and data analyses were performed employing the Gallios cyto-
fluorometer and the Kaluza software, respectively (Beckman Coulter).
Neutrophil-macrophage co-cultures. Monocytes from healthy donors were isolated from peripheral 
blood mononuclear cells (PBMC) by plastic adherence for 2 hours in serum-free media. They (1 × 106 cells/ml) 
were cultured for 7 days in RPMI1640 (Gibco) supplemented with 10% FCS and 25 ng/ml GM-CSF (Peprotech) 
to obtain monocyte-derived macrophages (MDMs). For neutrophil-macrophage co-culture experiments, puri-
fied neutrophils were stimulated with 50 pg of UMA per cell for 30 minutes and subsequently co-incubated 
with MDMs for 4 hours at a neutrophil:macrophage ratio of 4:1. At the indicated time points, neutrophils were 
Figure 8. Hypothetical model for the mechanisms beyond and the relevance of UMA clearance from 
hyperuricemic blood. UMA are the first crystals that are to be observed in hyperuricemic blood after several 
hours of incubation. They are instantly taken up by blood-borne phagocytes before they grow to nsMSU. 
The phagocytosis is fostered by opsonization with complement and fetuin. The UMA-loaded phagocytes are 
consecutively cleared from circulation by resident macrophages in the marginal zone of the spleen or the 
sinusoids of the liver. If not properly cleared, UMA grow to hazardous NET-inducing nsMSU. This carries the 
risk of intravascular tophus- and thrombus-formation and obstruction of the vessel.
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harvested and analyzed by flow cytometry. Internalization of UMA-containing neutrophils (labeled with PKH26, 
Sigma-Aldrich) by MDMs was confirmed by immunofluorescence microscopy. Macrophages were visualized 
by staining the actin cytoskeleton using phalloidin-FITC (Sigma-Aldrich). Where indicated, neutrophils were 
pre-labeled with 30 nM pHrodo Red SE (for 30 min, followed by washing twice) prior to their use in co-culture 
experiments with macrophages. To check the status of neutrophils after UMA exposure, we stained neutrophils 
for phosphatidyl serine (Annexin V-FITC, cat. no. K101–100, Biovision; according to the manufacturer’s instruc-
tions), CD11a (cat. no. 559875, BD Biosciences), CD18 (cat. no. 555923, BD Biosciences) and CD31 (cat. no. 
MHCD3101, ThermoFisher) and analyzed the expression of these surface molecules by flow cytometry after 2 
and 4 hours exposure to UMA.
NETosis assays. Purified neutrophils were stimulated with 50 pg of crystals per cell (either UMA or 
needle-shaped nsMSU) for up to 4 hours, either under static conditions or under conditions of flow. For the latter, 
cells were either treated with crystals on a rocking table or within a pump system yielding a laminar flow rate of 
20 ml/min (Ibidi). NETosis was assessed by quantifying DNA release with fluorometry or by immunofluores-
cence microscopy. For both techniques, extracellular DNA was stained with 100 nM Sytox Orange. The activity of 
NET-associated neutrophil elastase (NE) and myeloperoxidase (MPO) was determined by colorimetry, using 100 
μ M N-methoxysuccinyl-Ala-Ala-Pro-Val 4-nitroanilide (Sigma-Aldrich) or 1 mM 3′ ,5,5′ -tetra-methylbenzidine 
(eBioscience) as substrates for NE and MPO, respectively. For the measurement of ROS, neutrophils were stimu-
lated in the presence of 40 μ M 2′ ,7′ -dichlorofluorescin diacetate (Sigma-Aldrich).
Endothelial cell culture and real-time PCR. Confluent monolayers of human umbilicial vein endothelial 
cells (HUVEC) were treated under flow with UMA or nsMSU, either in the presence or absence of purified leu-
kocytes (i.e. erythrocyte-depleted whole blood). The viability and activation status of endothelial cells were ana-
lyzed by trypan blue exclusion assays, immunofluorescence microscopy or qRT-PCR. For immunofluorescence 
microscopy, HUVEC were stained for von Willebrand factor (Dako, A0082), NFKB p65 (Santa Cruz, sc-8008) 
and VE-cadherin (Santa Cruz, sc-6458). For qRT-PCR analyses, RNA was isolated from HUVEC with TRIzol© 
reagent (Ambion) and qRT-PCR analyses were performed on tumor necrosis factor alpha (TNF-α ; forward 
5′-CCCAGGCAGTCAGATCATCTTC-3′ and reverse 5′ -GGCAGAGGTAGGTCTGGTTC-3′ ), interleukin 6 
(IL-6; forward 5′-AGCCACTCACCTCTTCAGAAC-3′ and reverse 5′ -CGGGACTCTTTCCTCTGTACA-3′ ) 
and transforming growth factor beta (TGF-β ; forward 5′ -GGATGGTGGAAGGTCTCATTTTA-3′ and reverse 
5′-CGACTATGGTAGGGTTATCGACA-3′ ). GAPDH (forward 5′ -GAAGGTGAAGGTCGGAGT-3′ and 
reverse 5′-CTTTAGGGTAGTGGTAGA-3′ ) was used as housekeeping gene. Fold change was calculated using 
the delta-delta Ct method.
Production of nsMSU and UMA. A solution of 10 mM uric acid and 154 mM NaCl (pH 7.2) was agitated 
for 3 days to form nsMSU. The resultant crystals were washed with ethanol and sterilized at 180 °C for 2 hours 
prior to storage in PBS. For experiments with UMA we extensively grinded nsMSU under sterile conditions using 
Precellys ceramic (1.4 mm) beads. The similarity in size and shape between these artificially produced UMA and 
those UMA observed in hyperuricemic blood was assessed with polarized light microscopy.
Statistical analyses. Results are represented as mean ± SEM of at least three and up to ten independent 
experiments. Significance was either determined by Student’s t-test or one-way ANOVA followed by Bonferroni 
correction using GraphPad Prism. P-values ≤ 0.05 were considered as statistically significant.
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